- Home
- BSRR vs ATXS Comparison
BSRR vs ATXS Comparison
Compare BSRR & ATXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BSRR
- ATXS
- Stock Information
- Founded
- BSRR 1977
- ATXS 2008
- Country
- BSRR United States
- ATXS United States
- Employees
- BSRR N/A
- ATXS N/A
- Industry
- BSRR Major Banks
- ATXS Biotechnology: Pharmaceutical Preparations
- Sector
- BSRR Finance
- ATXS Health Care
- Exchange
- BSRR Nasdaq
- ATXS Nasdaq
- Market Cap
- BSRR 382.0M
- ATXS 401.2M
- IPO Year
- BSRR 1994
- ATXS 2015
- Fundamental
- Price
- BSRR $28.51
- ATXS $6.39
- Analyst Decision
- BSRR Buy
- ATXS Buy
- Analyst Count
- BSRR 2
- ATXS 6
- Target Price
- BSRR $33.50
- ATXS $32.00
- AVG Volume (30 Days)
- BSRR 33.8K
- ATXS 216.5K
- Earning Date
- BSRR 07-28-2025
- ATXS 08-15-2025
- Dividend Yield
- BSRR 3.52%
- ATXS N/A
- EPS Growth
- BSRR 18.55
- ATXS N/A
- EPS
- BSRR 2.90
- ATXS N/A
- Revenue
- BSRR $145,369,000.00
- ATXS N/A
- Revenue This Year
- BSRR $7.52
- ATXS N/A
- Revenue Next Year
- BSRR $4.93
- ATXS N/A
- P/E Ratio
- BSRR $9.78
- ATXS N/A
- Revenue Growth
- BSRR 2.12
- ATXS N/A
- 52 Week Low
- BSRR $22.42
- ATXS $3.56
- 52 Week High
- BSRR $35.13
- ATXS $12.92
- Technical
- Relative Strength Index (RSI)
- BSRR 36.78
- ATXS 54.33
- Support Level
- BSRR $27.99
- ATXS $6.59
- Resistance Level
- BSRR $29.00
- ATXS $7.21
- Average True Range (ATR)
- BSRR 0.82
- ATXS 0.37
- MACD
- BSRR -0.32
- ATXS -0.03
- Stochastic Oscillator
- BSRR 9.97
- ATXS 39.47
About BSRR Sierra Bancorp
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.
About ATXS Astria Therapeutics Inc.
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.